See the DrugPatentWatch profile for Neupogen
Neupogen Pricing and Payment Options
The cost of Neupogen (filgrastim) varies based on factors such as dosage, administration method, and the specific country or region. DrugPatentWatch.com provides detailed information on pricing, patents, and regulatory status for Neupogen.
Prescription Costs
Typical costs for a 300 mcg single-use syringe of Neupogen range from $30 to $100 per dose in the United States. However, prices may differ depending on the dispensing pharmacy, insurance coverage, or other factors. Patients can expect to pay anywhere from $400 to $1,200 for a standard 28-day supply, assuming three doses per week.
Insurance Coverage
Neupogen may be covered by Medicare Part B, Medicaid, or private insurance plans that include chemotherapy drugs. Patients should verify their coverage and cost-sharing responsibilities with their healthcare provider or insurance provider.
Discount Programs and Coupons
Neupogen manufacturer, Amgen, offers financial assistance programs to eligible patients. Programs like the Amgen Patient Foundation and the Neupogen Co-Pay Program can help reduce the out-of-pocket costs for patients. Additionally, some websites, like NeedyMeds, offer coupons and discount cards for Neupogen.
Generic and Biosimilar Options
The patent for Neupogen expires in [date], which may lead to the availability of generic or biosimilar versions of the medication. However, it's essential to note that biosimilars, while similar in composition and effect, may still have slightly different pricing structures.
Pricing by Country
Prices for Neupogen can vary significantly across countries. For example, in the United Kingdom, a 300 mcg dose costs approximately £25-£40 (around $32-$52 USD) per dose, while in Australia, the range is AU$40-AU$70 ($29-$50 USD) per dose.
Sources
1. DrugPatentWatch.com
2. Amgen Patient Foundation
3. Neupogen Co-Pay Program
4. NeedyMeds.org